XAIR: Beyond Air, Inc. Stock

by  •  • Comments Off on XAIR: Beyond Air, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 55.08
Enterprise Value ($M) 64.27
Book Value ($M) 23.47
Book Value / Share 0.51
Price / Book 2.35
NCAV ($M) 11.00
NCAV / Share 0.24
Price / NCAV 5.01

Profitability (mra)
Return on Invested Capital (ROIC) -1.65
Return on Assets (ROA) -0.97
Return on Equity (ROE) -1.59

Liquidity (mrq)
Quick Ratio 3.23
Current Ratio 3.39

Balance Sheet (mrq) ($M)
Current Assets 39.44
Assets 51.91
Liabilities 28.44
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-07 13G BlackRock Inc. 4.96 -3.67
02-14 13G/A Mosseri Marlio Charles 9.21 10.32

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S
2023-06-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-16 104,023 393,491 26.44
2024-05-15 54,373 336,837 16.14
2024-05-14 68,050 298,891 22.77
2024-05-13 97,521 533,279 18.29

(click for more detail)

Similar Companies
VANI – Vivani Medical, Inc. VERO – Venus Concept Inc.
VVOS – Vivos Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io